Vote Scores

Home / Companies / AngioDynamics, Inc. / 12 Nov 2024

Meeting · year to 30 June 2025223 filers reporting

AngioDynamics, Inc.: meeting of 12 Nov 2024

Votes reported on Form N-PX, item by item

223 Form N-PX filers reported votes at the AngioDynamics, Inc. meeting of 12 Nov 2024. Their records fall into 4 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 98.6% of reported votes for; 5 filers withheld from or voted against at least one nominee.

492 vote records from 82 filers. 1 of the 82 filers that marked the item either way voted against management.

98.8% for0.0% against1.2% other1.2% against management82 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

329 vote records from 222 filers. 11 of the 215 filers that marked the item either way voted against management. 7 filers reported this item without a management mark.

91.9% for5.0% against3.2% other5.1% against management222 filers96.9% for3.1% against0.0% other3.1% against management25,007,138 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

164 vote records from 82 filers. 1 of the 82 filers that marked the item either way voted against management.

98.8% for1.2% against1.2% against management82 filers100.0% for0.0% against0.0% against management10,415,904 reported shares
4

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

166 vote records from 84 filers. 14 of the 84 filers that marked the item either way voted against management.

82.1% for17.9% against16.7% against management84 filers87.0% for13.0% against13.0% against management10,450,734 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
DimensionalForForFor
State Street and SPDRForForFor
American CenturyForForFor
Franklin TempletonForForFor
InvescoForForFor
EquitableForForFor
Charles SchwabForForFor
Nuveen and TIAAForForFor
ProShares and ProFundsForForFor
John Hancock and ManulifeForForFor
Morgan Stanley, Eaton Vance and CalvertForForFor
J.P. MorganForForFor
Goldman SachsForForFor
PGIM and PrudentialForForFor
Jackson National fundsForForFor
Northern Trust and FlexSharesForForFor
SEIForForFor
T. Rowe PriceForForFor
Lincoln FinancialForForFor
VoyaForForFor
NationwideForForFor
Victory CapitalForForFor
Brighthouse FundsForForFor
Guggenheim and RydexForForFor
Columbia ThreadneedleForForFor
BNY MellonNo reportForNo report
PrincipalNo reportForNo report
Pacific Life fundsForForFor
Global XForForFor
TransamericaForForFor
AllianceBernsteinNo reportForNo report
DWSForForFor
AllspringNo reportForNo report
Neuberger BermanNo reportForNo report
Natixis and Loomis SaylesNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the AngioDynamics, Inc. meeting?

223 Form N-PX filers reported votes at the meeting of 12 Nov 2024. On say-on-pay, 11 of 215 voted against management (5.1%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by AngioDynamics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for AngioDynamics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing AngioDynamics, Inc. with a meeting date within three days of 12 Nov 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.